28 results on '"Nagakubo, D."'
Search Results
2. Shortened blood coagulation times in two distinct visceral obesity models, WBN/Kob-Lepr(fa) rats and diet-induced obese mice: PB 2.45–6
- Author
-
Asai, F, Nagakubo, D, Kaji, N, Takahashi, S, Shirai, M, and Ito, K
- Published
- 2013
3. Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia
- Author
-
Nakayama, T, primary, Hieshima, K, additional, Arao, T, additional, Jin, Z, additional, Nagakubo, D, additional, Shirakawa, A-K, additional, Yamada, Y, additional, Fujii, M, additional, Oiso, N, additional, Kawada, A, additional, Nishio, K, additional, and Yoshie, O, additional
- Published
- 2007
- Full Text
- View/download PDF
4. Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists
- Author
-
Mori, A., primary, Ogawa, K., additional, Someya, K., additional, Kunori, Y., additional, Nagakubo, D., additional, Yoshie, O., additional, Kitamura, F., additional, Hiroi, T., additional, and Kaminuma, O., additional
- Published
- 2007
- Full Text
- View/download PDF
5. CCL28: A Promising Biomarker for Assessing Salivary Gland Functionality and Maintaining Healthy Oral Environments.
- Author
-
Kaibori Y, Tamoto S, Okuda S, Matsuo K, Nakayama T, and Nagakubo D
- Abstract
The oral cavity serves as the primary path through which substances from the outside world enter our body. Therefore, it functions as a critical component of host defense. Saliva is essential for maintaining a stable oral environment by catching harmful agents, including pathogens, allergens, and chemicals, in the air or food. CCL28, highly expressed in mucosal tissues, such as the colon and salivary glands, is a chemokine that attracts CCR10/CCR3 expressing cells. However, the role of CCL28 in salivary gland formation remains unclear. In this study, we investigated the salivary gland structure in CCL28-deficient mice. Histological analysis showed decreased staining intensity of Alcian blue, which detects acidic mucous, reduced expression of MUC2, and higher infiltration of gram-positive bacteria in the salivary glands of CCL28-deficient mice. In addition, CCL28-deficient mice contained ectopically MUC2-expressed cells in the ducts and reduced the expression of cytokeratin 18, a marker for ductal cells, within the submandibular glands, resulting in decreased duct numbers. Additionally, the submandibular glands of CCL28-deficient mice showed reduced expression of several stem cell markers. These results suggest that CCL28 regulates saliva production via proper differentiation of salivary gland stem cells and could be a valuable biomarker of salivary gland function.
- Published
- 2024
- Full Text
- View/download PDF
6. Oral Microbiota: The Influences and Interactions of Saliva, IgA, and Dietary Factors in Health and Disease.
- Author
-
Nagakubo D and Kaibori Y
- Abstract
Recent advances in metagenomic analyses have made it easier to analyze microbiota. The microbiota, a symbiotic community of microorganisms including bacteria, archaea, fungi, and viruses within a specific environment in tissues such as the digestive tract and skin, has a complex relationship with the host. Recent studies have revealed that microbiota composition and balance particularly affect the health of the host and the onset of disease. Influences such as diet, food preferences, and sanitation play crucial roles in microbiota composition. The oral cavity is where the digestive tract directly communicates with the outside. Stable temperature and humidity provide optimal growth environments for many bacteria. However, the oral cavity is a unique environment that is susceptible to pH changes, salinity, food nutrients, and external pathogens. Recent studies have emphasized the importance of the oral microbiota, as changes in bacterial composition and balance could contribute to the development of systemic diseases. This review focuses on saliva, IgA, and fermented foods because they play critical roles in maintaining the oral bacterial environment by regulating its composition and balance. More attention should be paid to the oral microbiota and its regulatory factors in oral and systemic health.
- Published
- 2023
- Full Text
- View/download PDF
7. Limits to in vivo fate changes of epithelia in thymus and parathyroid by ectopic expression of transcription factors Gcm2 and Foxn1.
- Author
-
Nagakubo D, Hirakawa M, Iwanami N, and Boehm T
- Subjects
- Animals, Cell Differentiation, Epithelium metabolism, Mice, Parathyroid Glands metabolism, Thymus Gland metabolism, Ectopic Gene Expression, Forkhead Transcription Factors genetics, Forkhead Transcription Factors metabolism, Nuclear Proteins metabolism, Transcription Factors metabolism
- Abstract
The development of the parathyroid and the thymus from the third pharyngeal pouch depends on the activities of the Gcm2 and Foxn1 transcription factors, respectively, whose expression domains sharply demarcate two regions in the developing third pharyngeal pouch. Here, we have generated novel mouse models to examine whether ectopic co-expression of Gcm2 in the thymic epithelium and of Foxn1 in the parathyroid perturbs the establishment of organ fates in vivo. Expression of Gcm2 in the thymic rudiment does not activate a parathyroid-specific expression programme, even in the absence of Foxn1 activity. Co-expression of Foxn1 in the parathyroid fails to impose thymopoietic capacity. We conclude that the actions of Foxn1 and Gcm2 transcription factors are cell context-dependent and that they each require permissive transcription factor landscapes in order to successfully interfere with organ-specific cell fate., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
8. CCR4 Involvement in the Expansion of T Helper Type 17 Cells in a Mouse Model of Psoriasis.
- Author
-
Matsuo K, Kitahata K, Kaibori Y, Arima Y, Iwama A, Ito M, Hara Y, Nagakubo D, Quan YS, Kamiyama F, Oiso N, Kawada A, Yoshie O, and Nakayama T
- Subjects
- Animals, Cell Communication drug effects, Cell Communication immunology, Cell Proliferation drug effects, Cells, Cultured, Coculture Techniques, Dendritic Cells immunology, Disease Models, Animal, Humans, Imiquimod administration & dosage, Imiquimod immunology, Mice, Mice, Transgenic, Primary Cell Culture, Psoriasis drug therapy, Psoriasis pathology, Receptors, CCR4 antagonists & inhibitors, Receptors, CCR4 genetics, Skin immunology, Th17 Cells drug effects, Th17 Cells metabolism, Psoriasis immunology, Receptors, CCR4 metabolism, Skin pathology, Th17 Cells immunology
- Abstract
Psoriasis is a chronic skin disease associated with T helper (Th)17-mediated inflammation. Because CCR4 is a major chemokine receptor expressed on Th17 cells, we investigated the role of CCR4 in a modified imiquimod-induced psoriasis model that showed enhanced skin infiltration of Th17 cells. CCR4-deficient mice had less severe skin disease than wild-type mice. Th17 cells were decreased in the skin lesions and regional lymph nodes of CCR4-deficient mice. In the regional lymph nodes of wild-type mice, CD44
+ memory Th17 cells expressing CCR4 were found to be clustered with dendritic cells expressing CCL22, a ligand for CCR4. Such dendritic cell‒Th17 cell clusters were significantly decreased in CCR4-deficient mice. Similar results were obtained using the IL-23‒induced psoriasis model. In vitro, compound 22, a CCR4 antagonist, significantly reduced the expansion of Th17 cells in the coculture of CD11c+ dendritic cells and CD4+ T cells separately prepared from the regional lymph nodes of wild-type mice with psoriasis. In vivo, compound 22 ameliorated the psoriasis-like skin disease in wild-type mice with significant decreases of Th17 cells in the regional lymph nodes and skin lesions. Collectively, CCR4 is likely to play a role in the pathogenesis of psoriasis through the expansion of Th17 cells., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
9. A novel role for bone marrow-derived cells to recover damaged keratinocytes from radiation-induced injury.
- Author
-
Okano J, Nakae Y, Nakagawa T, Katagi M, Terashima T, Nagakubo D, Nakayama T, Yoshie O, Suzuki Y, and Kojima H
- Subjects
- Animals, Bone Marrow Cells radiation effects, Bone Marrow Transplantation, Cell Movement radiation effects, Cell Proliferation radiation effects, Chemokine CCL17 metabolism, Dermis pathology, Dermis radiation effects, Epidermis pathology, Epidermis radiation effects, Gene Deletion, HaCaT Cells, Humans, Keratinocytes radiation effects, Macrophages radiation effects, Mice, Inbred C57BL, Mice, Transgenic, Radiation, Ionizing, Receptors, CCR4 deficiency, Receptors, CCR4 metabolism, Signal Transduction radiation effects, Skin pathology, Skin radiation effects, Mice, Bone Marrow Cells pathology, Keratinocytes pathology, Radiation Injuries pathology
- Abstract
Exposure to moderate doses of ionizing radiation (IR), which is sufficient for causing skin injury, can occur during radiation therapy as well as in radiation accidents. Radiation-induced skin injury occasionally recovers, although its underlying mechanism remains unclear. Moderate-dose IR is frequently utilized for bone marrow transplantation in mice; therefore, this mouse model can help understand the mechanism. We had previously reported that bone marrow-derived cells (BMDCs) migrate to the epidermis-dermis junction in response to IR, although their role remains unknown. Here, we investigated the role of BMDCs in radiation-induced skin injury in BMT mice and observed that BMDCs contributed to skin recovery after IR-induced barrier dysfunction. One of the important mechanisms involved the action of CCL17 secreted by BMDCs on irradiated basal cells, leading to accelerated proliferation and recovery of apoptosis caused by IR. Our findings suggest that BMDCs are key players in IR-induced skin injury recovery.
- Published
- 2021
- Full Text
- View/download PDF
10. Retracing the evolutionary emergence of thymopoiesis.
- Author
-
Swann JB, Nusser A, Morimoto R, Nagakubo D, and Boehm T
- Subjects
- Animals, B-Lymphocytes, Mammals, Mice, Mice, Transgenic, Phylogeny, Vertebrates, Lymphopoiesis genetics, T-Lymphocytes
- Abstract
The onset of lymphocyte development in the vertebrate primordial thymus, about 500 million years ago, represents one of the foundational events of the emerging adaptive immune system. Here, we retrace the evolutionary trajectory of thymopoiesis, from early vertebrates to mammals, guided by members of the Foxn1/4 transcription factor gene family, which direct the differentiation of the thymic microenvironment. Molecular engineering in transgenic mice recapitulated a gene duplication event, exon replacements, and altered expression patterns. These changes predictably modified the lymphopoietic characteristics of the thymus, identifying molecular features contributing to conversion of a primordial bipotent lymphoid organ to a tissue specializing in T cell development. The phylogenetic reconstruction associates increasing efficiency of T cell generation with diminishing B cell-generating capacity of the thymus during jawed vertebrate evolution., (Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).)
- Published
- 2020
- Full Text
- View/download PDF
11. CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice.
- Author
-
Matsuo K, Nagakubo D, Komori Y, Fujisato S, Takeda N, Kitamatsu M, Nishiwaki K, Quan YS, Kamiyama F, Oiso N, Kawada A, Yoshie O, and Nakayama T
- Subjects
- Animals, Bacterial Toxins administration & dosage, Bacterial Toxins immunology, Dermatitis, Atopic pathology, Disease Models, Animal, Eosinophils immunology, Humans, Mast Cells immunology, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Ovalbumin administration & dosage, Ovalbumin immunology, Receptors, CCR4 antagonists & inhibitors, Receptors, CCR4 genetics, Receptors, CCR4 metabolism, Skin cytology, Skin immunology, Skin pathology, Th17 Cells metabolism, Th2 Cells metabolism, Dermatitis, Atopic immunology, Receptors, CCR4 immunology, Th17 Cells immunology, Th2 Cells immunology
- Abstract
Atopic dermatitis is a chronic inflammatory skin disease involving T-helper (Th) 2 cells, eosinophils, and mast cells. Although CCR4 is a major chemokine receptor expressed on Th2 cells and regarded as a potential therapeutic target for allergic diseases, its role in atopic dermatitis remains unclear. Here, by using a hydrogel patch as a transcutaneous delivery device for ovalbumin (an antigen) and Staphylococcus aureus δ-toxin (a mast cell activator), we efficiently induced acute atopic dermatitis-like skin lesions in BALB/c mice, a strain prone to Th2 responses, which were characterized by increased numbers of eosinophils, mast cells, and CCR4-expressing Th2 cells in the skin lesions; elevated levels of total and ovalbumin-specific IgE in the sera; and increased expression of IL-4, IL-17A, IL-22, CCL17, CCL22, and CCR4 in the skin lesions. Of note, the same model was less efficient in C57BL/6 mice, a strain prone to Th1 responses. Using this atopic dermatitis model in BALB/c mice, we demonstrated that CCR4-deficiency or a CCR4 antagonist ameliorated the allergic responses. Collectively, these results demonstrate that CCR4 plays a pivotal role in skin allergic inflammation of BALB/c mice by recruiting CCR4-expressing Th2 cells and Th17 cells., (Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
12. Fundamental parameters of the developing thymic epithelium in the mouse.
- Author
-
Hirakawa M, Nagakubo D, Kanzler B, Avilov S, Krauth B, Happe C, Swann JB, Nusser A, and Boehm T
- Subjects
- Animals, Cell Communication, Cellular Microenvironment, Epithelial Cells cytology, Epithelial Cells metabolism, Epithelium metabolism, Gene Expression, Genes, Reporter, Mice, Transgenic, Stromal Cells cytology, Stromal Cells metabolism, Thymus Gland metabolism, Epithelium embryology, Thymus Gland embryology
- Abstract
The numbers of thymic epithelial cells (TECs) and thymocytes steadily increase during embryogenesis. To examine this dynamic, we generated several TEC-specific transgenic mouse lines, which express fluorescent proteins in the nucleus, the cytosol and in the membranes under the control of the Foxn1 promoter. These tools enabled us to determine TEC numbers in tissue sections by confocal fluorescent microscopy, and in the intact organ by light-sheet microscopy. Compared to histological procedures, flow cytometric analysis of thymic cellularity is shown to underestimate the numbers of TECs by one order of magnitude; using enzymatic digestion of thymic tissue, the loss of cortical TECs (cTECs) is several fold greater than that of medullary TECs (mTECs), although different cTEC subsets appear to be still present in the final preparation. Novel reporter lines driven by Psmb11 and Prss16 promoters revealed the trajectory of differentiation of cTEC-like cells, and, owing to the additional facility of conditional cell ablation, allowed us to follow the recovery of such cells after their depletion during embryogenesis. Multiparametric histological analyses indicate that the new transgenic reporter lines not only reveal the unique morphologies of different TEC subsets, but are also conducive to the analysis of the complex cellular interactions in the thymus.
- Published
- 2018
- Full Text
- View/download PDF
13. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
- Author
-
Yamamoto S, Matsuo K, Nagakubo D, Higashiyama S, Nishiwaki K, Oiso N, Kawada A, Yoshie O, and Nakayama T
- Subjects
- Adjuvants, Immunologic, Animals, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Cell Line, Dendritic Cells immunology, Epitopes immunology, Gene Expression drug effects, Immunoglobulin G, Interferon-gamma genetics, Interferon-gamma metabolism, Interleukin-4 genetics, Interleukin-4 metabolism, Mice, Inbred BALB C, Mice, Inbred C57BL, Muscles immunology, Ovalbumin immunology, Receptors, CCR4 deficiency, T-Lymphocytes, Regulatory immunology, Lymph Nodes immunology, Piperazines pharmacology, Piperidines pharmacology, Pyridines pharmacology, Pyrimidines pharmacology, Receptors, CCR4 antagonists & inhibitors, Receptors, CCR4 physiology, T-Lymphocytes, Regulatory drug effects, Vaccines
- Abstract
CCR4 is a major chemokine receptor expressed by Treg cells that downregulate immune responses. Here, we investigated the role of CCR4-mediated Treg cell recruitment in antigen-specific immune responses. CCR4-deficient mice immunized intramuscularly with ovalbumin (OVA) showed enhanced OVA-specific IgG responses. Furthermore, intramuscular administration of OVA induced the expression of MDC/CCL22, a ligand for CCR4, in macrophages of the muscle tissues, and enhanced the recruitment of CCR4+ Treg cells in wild-type mice, whereas this recruitment of Treg cells was severely impaired in CCR4-deficient mice. Furthermore, OVA-loaded dendritic cells (DCs) derived from the muscle injection site of CCR4-deficient mice had an upregulated expression of the DC activation marker CD40 and 86, and the lymphoid organ homing receptor CCR7 resulting in an increased number of migratory DCs in the regional lymph node. Compound 22, a CCR4 antagonist, also inhibited the recruitment of Treg cells to the muscle tissue, and further enhanced DC activation and homing to the regional lymph node. Consequently, Compound 22 enhanced OVA-specific IgG responses, and the expression levels of IL-4 and IFN-γ in CD4+ T cells and the levels of IFN-γ in CD8+ T cells. Finally, intramuscular administration of OVA and Compound 22 significantly inhibited the growth of OVA-expressing tumors. Collectively, CCR4 plays a pivotal role in Treg cell recruitment to the muscle tissue, and intramuscular administration of CCR4 antagonists may be a promising approach for enhancing vaccine efficacy., (Copyright © 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
14. Genetic and non-genetic determinants of thymic epithelial cell number and function.
- Author
-
Nagakubo D, Krauth B, and Boehm T
- Subjects
- Animals, Biomarkers, Female, Humans, Immunophenotyping, Male, Mice, Mice, Transgenic, Phenotype, Sex Factors, Thymocytes metabolism, Epithelial Cells metabolism, Thymus Gland metabolism
- Abstract
The thymus is the site of T cell development in vertebrates. In general, the output of T cells is determined by the number of thymic epithelial cells (TECs) and their relative thymopoietic activity. Here, we show that the thymopoietic activity of TECs differs dramatically between individual mouse strains. Moreover, in males of some strains, TECs perform better on a per cell basis than their counterparts in females; in other strains, this situation is reversed. Genetic crosses indicate that TEC numbers and thymopoietic capacity are independently controlled. Long-term analysis of functional parameters of TECs after castration provides evidence that the number of Foxn1-expressing TECs directly correlates with thymopoietic activity. Our study highlights potential complications that can arise when comparing parameters of TEC biology across different genetic backgrounds; these could affect the interpretation of the outcomes of interventions aimed at modulating thymic activity in genetically diverse populations, such as humans.
- Published
- 2017
- Full Text
- View/download PDF
15. Autoimmunity associated with chemically induced thymic dysplasia.
- Author
-
Nagakubo D, Swann JB, Birmelin S, and Boehm T
- Subjects
- Anaplasia, Animals, Antineoplastic Agents pharmacology, Apoptosis, Autoimmunity, Aziridines pharmacology, Disease Models, Animal, Forkhead Transcription Factors genetics, Humans, Lymphopenia, Mice, Mice, Inbred C57BL, Mice, Transgenic, Inflammatory Bowel Diseases immunology, T-Lymphocytes physiology, Thymus Gland pathology
- Abstract
Autoimmune and inflammatory conditions are frequent complications in patients with reduced numbers of T cells. Here, we describe a mouse model of thymic stromal dysplasia resulting in peripheral T-cell lymphopenia. In Foxn1:CFP-NTR transgenic mice, the bacterial nitroreductase enzyme is expressed in thymic epithelial cells and converts the prodrug CB1954 into a cytotoxic agent. This strategy enables titratable and durable destruction of thymopoietic tissue in early embryogenesis. Our results indicate that the resulting low levels of thymic capacity for T-cell production create a predisposition for the development of a complex autoimmune syndrome, chiefly characterized by inflammatory bowel disease and lymphocytic organ infiltrations. We conclude that the Foxn1:CFP-NTR transgenic mouse strain represents a suitable animal model to optimize established clinical protocols, such as thymus transplantation, to correct various forms of thymic dysplasia and to explore novel treatment options., (© The Author 2017. Published by Oxford University Press on behalf of The Japanese Society for Immunology.)
- Published
- 2017
- Full Text
- View/download PDF
16. Effects of high-fat diet and fructose-rich diet on obesity, dyslipidemia and hyperglycemia in the WBN/Kob-Lepr fa rat, a new model of type 2 diabetes mellitus.
- Author
-
Namekawa J, Takagi Y, Wakabayashi K, Nakamura Y, Watanabe A, Nagakubo D, Shirai M, and Asai F
- Subjects
- Animals, Blood Glucose metabolism, Diabetes Mellitus, Experimental etiology, Diabetes Mellitus, Type 2 physiopathology, Disease Models, Animal, Male, Rats, Rats, Wistar, Diet, High-Fat adverse effects, Dyslipidemias etiology, Fructose administration & dosage, Hyperglycemia etiology, Obesity etiology
- Abstract
Obesity and type 2 diabetes mellitus (T2DM) are occurring at epidemic-like rates, and these epidemics appear to have emerged largely from changes in daily diet. In the present study, we compared effects of high-fat diet (HFD) and fructose-rich diet (FRD) in WBN/Kob-Lepr
fa (WBKDF) rats that spontaneously develop obesity, dyslipidemia and T2DM. After a 4-week feeding of each diet, WBKDF-HFD and WBKDF-FRD rats exhibited aggravated obesity and dyslipidemia compared with WBKDF rats fed standard diet (STD). In contrast, hyperglycemia developed in WBKDF-STD rats was significantly inhibited in WBKDF-FRD rats, but not in WBKDF-HFD rats. The present study demonstrated that the 4-week feeding of HFD and FRD caused diet-induced obesity with a distinct phenotype in the glucose metabolism in WBKDF rats.- Published
- 2017
- Full Text
- View/download PDF
17. Conversion of the thymus into a bipotent lymphoid organ by replacement of FOXN1 with its paralog, FOXN4.
- Author
-
Swann JB, Weyn A, Nagakubo D, Bleul CC, Toyoda A, Happe C, Netuschil N, Hess I, Haas-Assenbaum A, Taniguchi Y, Schorpp M, and Boehm T
- Subjects
- Animals, B-Lymphocytes physiology, Cells, Cultured, Epithelial Cells metabolism, Eye Proteins metabolism, Forkhead Transcription Factors metabolism, Gene Expression, Genetic Engineering, Hematopoiesis, Extramedullary, Lymphoid Tissue, Lymphopoiesis, Mice, Mice, Transgenic, Oryzias, Phylogeny, T-Lymphocytes physiology, Thymus Gland cytology, Zebrafish, Eye Proteins genetics, Forkhead Transcription Factors genetics, Thymus Gland metabolism
- Abstract
The thymus is a lymphoid organ unique to vertebrates, and it provides a unique microenvironment that facilitates the differentiation of immature hematopoietic precursors into mature T cells. We subjected the evolutionary trajectory of the thymic microenvironment to experimental analysis. A hypothetical primordial form of the thymus was established in mice by replacing FOXN1, the vertebrate-specific master regulator of thymic epithelial cell function, with its metazoan ancestor, FOXN4, thereby resetting the regulatory and coding changes that have occurred since the divergence of these two paralogs. FOXN4 exhibited substantial thymopoietic activity. Unexpectedly, histological changes and a functional imbalance between the lymphopoietic cytokine IL7 and the T cell specification factor DLL4 within the reconstructed thymus resulted in coincident but spatially segregated T and B cell development. Our results identify an evolutionary mechanism underlying the conversion of a general lymphopoietic organ to a site of exclusive T cell generation., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
18. Prophylactic effects of the glucagon-like Peptide-1 analog liraglutide on hyperglycemia in a rat model of type 2 diabetes mellitus associated with chronic pancreatitis and obesity.
- Author
-
Nagakubo D, Shirai M, Nakamura Y, Kaji N, Arisato C, Watanabe S, Takasugi A, and Asai F
- Subjects
- Adiposity drug effects, Age Factors, Animals, Body Weight drug effects, Dose-Response Relationship, Drug, Glucagon-Like Peptide 1 pharmacology, Glucagon-Like Peptide 1 therapeutic use, Hyperglycemia etiology, Insulin blood, Liraglutide, Male, Pancreatitis, Chronic pathology, Pre-Exposure Prophylaxis methods, Rats, Diabetes Mellitus, Type 2 complications, Disease Models, Animal, Glucagon-Like Peptide 1 analogs & derivatives, Hyperglycemia prevention & control, Obesity complications, Pancreatitis, Chronic complications
- Abstract
The objective of this study was to investigate the effects of liraglutide, an analog of human glucagon-like peptide 1 (GLP1), on WBN/Kob-Lepr(fa) (fa/fa) rats, which spontaneously develop type 2 diabetes mellitus with pancreatic disorder and obesity. Male fa/fa rats (age, 7 wk) were allocated into 4 groups and received liraglutide (37.5, 75, 150 μg/kg SC) or saline (control group) once daily for 4 wk. All rats in the control group became overweight and developed hyperglycemia as they aged. Although the rats given liraglutide showed a dose-dependent reduction in food intake, no significant effects on body weight or fat content occurred. In the liraglutide groups, the development of hyperglycemia was suppressed, even as plasma insulin concentrations increased in a dose-dependent manner. Intravenous glucose tolerance testing of the liraglutide-treated rats confirmed improvement of glucose tolerance and enhanced insulin secretion. Histologic examination revealed increased numbers of pancreatic β-cell type islet cells and increased proliferation of epithelial cells of the small ducts in the liraglutide-treated groups. Although our study did not reveal a significant decrease in obesity after liraglutide administration, the results suggest a marked antidiabetic effect characterized by increased insulin secretion in fa/fa rats with pancreatic disorders.
- Published
- 2014
19. Role of insulin resistance in the pathogenesis and development of type 2 diabetes in WBN/Kob-Lepr(fa) rats.
- Author
-
Okuno A, Kaji N, Takahashi A, Nagakubo D, Ohno-Ichiki K, Shirai M, and Asai F
- Subjects
- Age Factors, Animals, Area Under Curve, Chromans pharmacology, Insulin blood, Male, Rats, Rats, Mutant Strains, Rats, Wistar, Thiazolidinediones pharmacology, Troglitazone, Diabetes Mellitus, Type 2 physiopathology, Disease Models, Animal, Insulin Resistance physiology
- Abstract
WBN/Kob-Lepr(fa) (fa/fa) rats have been identified as a new animal model of type 2 diabetes (T2DM), as they are characterized by impaired pancreatic insulin secretion and severe insulin resistance. Our previous study demonstrated impaired insulin secretion and its involvement in hyperglycemia in fa/fa rats. The present study was aimed at elucidating the role of insulin resistance in the development and progression of diabetes in these animals. Troglitazone (TGZ) was used as an insulin sensitizer. Insulin resistance and insulin secretory capacity were measured by a homeostasis model assessment of insulin resistance and the area under the blood concentration-time curve for plasma insulin levels after intravenous glucose tolerance testing, respectively. The fa/fa rats exhibited marked insulin resistance between 5 and 11 weeks of age, compared with age-matched Wistar rats. The insulin secretory capacity of fa/fa rats was higher than that of Wistar rats at 5 weeks of age, but decreased by 50% between 9 and 11 weeks of age. The fa/fa rats were fed a standard diet, with or without 0.2% w/w TGZ, for 4 weeks. Treatment with TGZ significantly improved insulin resistance, hyperglycemia and hypertriglyceridemia in both prophylactic and therapeutic study groups. These results suggest that insulin resistance is markedly involved in the development and progression of T2DM in fa/fa rats.
- Published
- 2013
- Full Text
- View/download PDF
20. Shortened blood coagulation times in genetically obese rats and diet-induced obese mice.
- Author
-
Kaji N, Nagakubo D, Hashida S, Takahashi S, Kuratani M, Hirai N, Shirai M, and Asai F
- Subjects
- Animals, Blood Glucose metabolism, Mice, Mice, Inbred C57BL, Mice, Obese, Obesity, Abdominal etiology, Partial Thromboplastin Time, Prothrombin Time, Rats, Rats, Wistar, Blood Coagulation physiology, Obesity, Abdominal physiopathology
- Abstract
The aim of this study was to investigate blood coagulation times in genetically obese rats and diet-induced obese (DIO) mice in order to clarify the relationship between visceral obesity and blood coagulation. WBN/Kob-Lepr(fa) (fa/fa) rats, a genetically obese model, exhibited a significantly shorter activated partial thromboplastin time (aPTT) and prothrombin time (PT) than age-matched Wistar rats. C57BL/6J mice fed a high-fat diet (60%), a DIO model, exhibited significantly shorter aPTT, PT and thrombin time than lean mice fed a standard diet. Higher body weight, visceral fat weight and insulin resistance were also shared by fa/fa rats and DIO mice. These results suggest that visceral obesity is related to accelerated blood coagulation in addition to disrupted metabolism of glucose and lipids.
- Published
- 2013
- Full Text
- View/download PDF
21. c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein.
- Author
-
Hieshima K, Nagakubo D, Shigeta A, Tanaka Y, Hoshino H, Tsukasaki K, Yamada Y, and Yoshie O
- Subjects
- Blotting, Western, CD4-Positive T-Lymphocytes metabolism, CD4-Positive T-Lymphocytes virology, CREB-Binding Protein genetics, Cell Transformation, Viral, Gene Products, env genetics, Gene Products, env metabolism, Gene Products, tax antagonists & inhibitors, Gene Products, tax genetics, HTLV-I Infections genetics, HTLV-I Infections virology, Human T-lymphotropic virus 1 genetics, Humans, Jurkat Cells, Leukemia-Lymphoma, Adult T-Cell genetics, Leukemia-Lymphoma, Adult T-Cell metabolism, Leukemia-Lymphoma, Adult T-Cell virology, Luciferases metabolism, Promoter Regions, Genetic, Proto-Oncogene Proteins c-maf antagonists & inhibitors, Proto-Oncogene Proteins c-maf genetics, RNA, Messenger genetics, RNA, Small Interfering genetics, Receptors, CCR4 genetics, Receptors, CCR4 metabolism, Retroviridae Proteins, Oncogenic genetics, Retroviridae Proteins, Oncogenic metabolism, Reverse Transcriptase Polymerase Chain Reaction, Th2 Cells, Transcriptional Activation, Virion, CREB-Binding Protein metabolism, Gene Products, tax metabolism, HTLV-I Infections metabolism, Human T-lymphotropic virus 1 metabolism, Proto-Oncogene Proteins c-maf metabolism
- Abstract
Latent infection of human T-cell leukemia virus type 1 (HTLV-1) is considered to be preferentially associated with CCR4(+) CD4(+) T cells. Here we report that c-Maf, one of the critical transcription factors for Th2 differentiation, suppresses the transcriptional activity of HTLV-1 Tax by competing for CREB-binding protein. Notably, c-maf expression is selectively induced in a fraction of CCR4(+) CD4(+) T cells upon activation. Furthermore, c-Maf significantly decreases Tax-induced HTLV-1 envelope gp46 gene expression from an infectious HTLV-1 molecular clone and tax expression in a cell-free HTLV-1 infection system. Collectively, c-Maf may play a role in latent infection of HTLV-1 in CCR4(+) CD4(+) T cells by negatively regulating Tax activity., (© 2011 Japanese Cancer Association.)
- Published
- 2011
- Full Text
- View/download PDF
22. T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma.
- Author
-
Moriwaki A, Inoue H, Nakano T, Matsunaga Y, Matsuno Y, Matsumoto T, Fukuyama S, Kan-O K, Matsumoto K, Tsuda-Eguchi M, Nagakubo D, Yoshie O, Yoshimura A, Kubo M, and Nakanishi Y
- Subjects
- Adoptive Transfer, Animals, CD4-Positive T-Lymphocytes immunology, Cell Differentiation, Disease Models, Animal, Down-Regulation, Heterozygote, Lymphocyte Depletion, Mice, Receptors, CCR3 metabolism, Receptors, CCR4 metabolism, Suppressor of Cytokine Signaling 3 Protein, Th2 Cells cytology, Th2 Cells immunology, Asthma immunology, Asthma physiopathology, Bronchial Hyperreactivity immunology, CD4-Positive T-Lymphocytes metabolism, RNA, Small Interfering metabolism, Suppressor of Cytokine Signaling Proteins metabolism
- Abstract
CD4(+) T cells, particularly T helper (Th) 2 cells, play a pivotal role in the pathophysiology of allergic asthma. Suppressor of cytokine signaling (SOCS) proteins control the balance of CD4(+) T cell differentiation. Mice that lack SOCS3 in T cells by crossing SOCS3-floxed mice with Lck-Cre-transgenic mice have reduced allergen-induced eosinophilia in the airways. Here, we studied the effects of SOCS3 silencing with small interfering (si) RNA in primary CD4(+) T cells on Th2 cell differentiation and on asthmatic responses in mice. Th2 cells were generated from ovalbumin (OVA)-specific T cell receptor-transgenic mice in vitro and transferred into recipient mice. Transfection of SOCS3-specific siRNA attenuated Th2 response in vitro. Adoptive transfer of SOCS3-siRNA T cells exhibited markedly suppressed airway hyperresponsiveness and eosinophilia after OVA challenge, with a concomitant decrease in OVA-specific CD4(+) T cell accumulation in the airways. To investigate the mechanism of this impaired CD4(+) T cell accumulation, we inactivated SOCS3 of T cells by crossing SOCS3-floxed (SOCS3(flox/flox)) mice with CD4-Cre transgenic mice. CD4-Cre × SOCS3(flox/flox) mice exhibited fewer IL-4-producing cells and more reduced eosinophil infiltration in bronchoalveolar lavage fluids than control mice in a model of OVA-induced asthma. Expression of CCR3 and CCR4 in CD4(+) T cells was decreased in CD4-Cre × SOCS3(flox/flox) mice. CCR4 expression was also decreased in CD4(+) T cells after transfer of SOCS3 siRNA-treated T cells. These findings suggest that the therapeutic modulation of SOCS3 expression in CD4(+) T cells might be effective in preventing the development of allergic asthma.
- Published
- 2011
- Full Text
- View/download PDF
23. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder.
- Author
-
Takegawa S, Jin Z, Nakayama T, Oyama T, Hieshima K, Nagakubo D, Shirakawa AK, Tsuzuki T, Nakamura S, and Yoshie O
- Subjects
- B-Lymphocytes metabolism, Forkhead Transcription Factors metabolism, Humans, Immunohistochemistry, Lymphoproliferative Disorders metabolism, Tumor Cells, Cultured, B-Lymphocytes virology, Chemokine CCL17 metabolism, Chemokine CCL22 metabolism, Herpesvirus 4, Human pathogenicity, Lymphoproliferative Disorders virology, Viral Matrix Proteins metabolism
- Abstract
Age-related Epstein-Barr virus-positive (EBV(+)) B-cell lymphoproliferative disorder (ALPD) is a disease entity identified from a large-scale re-survey of cases diagnosed as diffuse large B-cell lymphoma. ALPD is a group of EBV(+) polymorphic B-cell lymphoma typically seen in elderly patients. An age-associated decline in host immunity against EBV might be partly responsible for the pathogenesis of ALPD. Histologically, ALPD is often characterized by a minor proportion of EBV-encoded RNA-positive tumor cells in a background of extensive cellular infiltration, similar to that of classical Hodgkin's lymphoma. In contrast to Hodgkin and Reed-Sternberg cells, ALPD tumor cells are clearly positive for B cell markers CD20 and/or CD79a. Hodgkin and Reed-Sternberg cells produce various chemokines, including CCL17 and CCL22, that attract chemokine receptor CCR4-expressing Th2 cells and regulatory T cells. Previously, we have shown that EBV-immortalized B cells also produce CCL17 and CCL22 through latent membrane protein 1 (LMP1)-mediated activation of nuclear factor kappaB. Here we examined expression of CCL17 and CCL22 in ALPD. ALPD tumor cells were often heterogeneous in size in accordance with the differential expression of EBV latent genes at the single cell level. LMP1-expressing tumor cells were typically large in size and selectively positive for CCL17 and CCL22. CCR4(+) cells and forkhead box protein 3(+) regulatory T cells were abundantly present, and the majority of forkhead box protein 3(+) cells were CCR4(+). Collectively, our data show production of CCL17 and CCL22 by LMP1(+) large-sized tumor cells and accumulation of CCR4-expressing cells including regulatory T cells in ALPD.
- Published
- 2008
- Full Text
- View/download PDF
24. Novel antiviral activity of chemokines.
- Author
-
Nakayama T, Shirane J, Hieshima K, Shibano M, Watanabe M, Jin Z, Nagakubo D, Saito T, Shimomura Y, and Yoshie O
- Subjects
- Humans, Microscopy, Electron, Recombinant Proteins pharmacology, Virion drug effects, Virion ultrastructure, Antiviral Agents pharmacology, Chemokines pharmacology, Herpesvirus 1, Human drug effects
- Abstract
Antimicrobial peptides are a diverse family of small, mostly cationic polypeptides that kill bacteria, fungi and even some enveloped viruses, while chemokines are a group of mostly cationic small proteins that induce directed migration of leukocytes through interactions with a group of seven transmembrane G protein-coupled receptors. Recent studies have shown that antimicrobial peptides and chemokines have substantially overlapping functions. Thus, while some antimicrobial peptides are chemotactic for leukocytes, some chemokines can kill a wide range of bacteria and fungi. Here, we examined a possible direct antiviral activity of chemokines against an enveloped virus HSV-1. Among 22 human chemokines examined, chemokines such as MIP-1 alpha/CCL3, MIP-1 beta/CCL4 and RANTES/CCL5 showed a significant direct antiviral activity against HSV-1. It is intriguing that these chemokines are mostly known to be highly expressed by effector CD8+ T cells. The chemokines with a significant anti-HSV-1 activity commonly bound to HSV-1 virions via envelope glycoprotein gB. Electron microscopy revealed that the chemokines with a significant anti-HSV-1 activity were commonly capable of generating pores in the envelope of HSV-1. Thus, some chemokines have a significant direct antiviral activity against HSV-1 in vitro and may have a potential role in host defense against HSV-1 as a direct antiviral agent.
- Published
- 2006
- Full Text
- View/download PDF
25. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus.
- Author
-
Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, and Yoshie O
- Subjects
- Blood Donors, Cell Line, Transformed, Chemokine CCL17, Chemokine CCL22, Chemokines biosynthesis, Chemokines genetics, Chemokines, CC blood, Chemokines, CC genetics, Humans, Infectious Mononucleosis immunology, Infectious Mononucleosis virology, Th2 Cells immunology, B-Lymphocytes virology, Chemokines, CC biosynthesis, Herpesvirus 4, Human immunology, Viral Matrix Proteins immunology
- Abstract
Chemokines are likely to play important roles in the pathophysiology of diseases associated with Epstein-Barr virus (EBV). Here, we have analyzed the repertoire of chemokines expressed by EBV-infected B cells. EBV infection of B cells induced expression of TARC/CCL17 and MDC/CCL22, which are known to attract Th2 cells and regulatory T cells via CCR4, and also upregulated constitutive expression of MIP-1 alpha/CCL3, MIP-1 beta/CCL4, and RANTES/CCL5, which are known to attract Th1 cells and cytotoxic T cells via CCR5. Accordingly, EBV-immortalized B cells secreted these chemokines, especially CCL3, CCL4, and CCL22, in large quantities. EBV infection or stable expression of LMP1 also induced CCL17 and CCL22 in a B-cell line, BJAB. The inhibitors of the TRAF/NF-kappa B pathway (BAY11-7082) and the p38/ATF2 pathway (SB202190) selectively suppressed the expression of CCL17 and CCL22 in EBV-immortalized B cells and BJAB-LMP1. Consistently, transient-transfection assays using CCL22 promoter-reporter constructs demonstrated that two NF-kappa B sites and a single AP-1 site were involved in the activation of the CCL22 promoter by LMP1. Finally, serum CCL22 levels were significantly elevated in infectious mononucleosis. Collectively, LMP1 induces CCL17 and CCL22 in EBV-infected B cells via activation of NF-kappa B and probably ATF2. Production of CCL17 and CCL22, which attract Th2 and regulatory T cells, may help EBV-infected B cells evade immune surveillance by Th1 cells. However, the concomitant production of CCL3, CCL4, and CCL5 by EBV-infected B cells may eventually attract Th1 cells and cytotoxic T cells, leading to elimination of EBV-infected B cells at latency III and to selection of those with limited expression of latent genes.
- Published
- 2004
- Full Text
- View/download PDF
26. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells.
- Author
-
Usui T, Murai T, Tanaka T, Yamaguchi K, Nagakubo D, Lee CM, Kiyomi M, Tamura S, Matsuzawa Y, and Miyasaka M
- Subjects
- Animals, Biomarkers, Cell Line, Endothelial Growth Factors metabolism, Gene Expression Regulation, In Vitro Techniques, Intercellular Signaling Peptides and Proteins metabolism, Lymphoid Tissue metabolism, Lymphokines metabolism, Mice, Mice, Inbred BALB C, Neoplasm Proteins biosynthesis, Neoplasm Proteins metabolism, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Endothelium metabolism, Neoplasm Proteins genetics, Venules metabolism
- Abstract
Previous results have indicated that mac25/angiomodulin (AGM) is expressed in lymph node (LN) high endothelial venules (HEV), the specialized venules that support efficient lymphocyte transendothelial migration. How mac25/AGM's endothelial expression pattern is regulated in situ remains unknown. Here, we demonstrate that in mouse LN blood vessels, including HEV, mac25/AGM is localized, unlike previous reports, not to the luminal or lateral regions bordering the endothelial cells (EC), but exclusively to the basal lamina that is in direct association with EC. In the spleen, mac25/AGM was expressed in the vascular basal lamina, in direct association with smooth muscle cells and pericytes, but not with EC. In addition, we report herein that mac25/AGM is an inducible marker for activated EC. In inflamed tissues, mac25/AGM expression was strongly induced in the abluminal region of blood vessels. In vitro, mac25/AGM was readily induced in EC upon activation with pro-inflammatory cytokines such as tumor necrosis factor-alpha, indicating that mac25/AGM is an activated EC marker. mac25/AGM binds vascular endothelial growth factor and, together with its strict abluminal localization, it is suggested that mac25/AGM has a specific function(s) in the subendothelium of activated blood vessels such as capturing humoral factors produced in the vicinity of HEV.
- Published
- 2002
- Full Text
- View/download PDF
27. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.
- Author
-
Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, and Miyasaka M
- Subjects
- Animals, Biotinylation, Blotting, Western, Chondroitin pharmacology, Chondroitin ABC Lyase pharmacology, Chondroitinases and Chondroitin Lyases pharmacology, Cross-Linking Reagents pharmacology, DNA, Complementary metabolism, Dose-Response Relationship, Drug, Electrophoresis, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Glycosaminoglycans metabolism, Humans, Hyaluronic Acid pharmacology, Keratan Sulfate pharmacology, Kinetics, Lectins, C-Type, Lipid Metabolism, Mice, Protein Binding, Transfection, Tumor Cells, Cultured, Versicans, Chondroitin Sulfate Proteoglycans metabolism, Chondroitin Sulfates metabolism, Dermatan Sulfate metabolism, Hyaluronan Receptors metabolism, L-Selectin metabolism, P-Selectin metabolism, Proteoglycans metabolism
- Abstract
Here we show that a large chondroitin sulfate proteoglycan, versican, derived from a renal adenocarcinoma cell line ACHN, binds L-selectin, P-selectin, and CD44. The binding was mediated by the interaction of the chondroitin sulfate (CS) chain of versican with the carbohydrate-binding domain of L- and P-selectin and CD44. The binding of versican to L- and P-selectin was inhibited by CS B, CS E, and heparan sulfate (HS) but not by any other glycosaminoglycans tested. On the other hand, the binding to CD44 was inhibited by hyaluronic acid, chondroitin (CH), CS A, CS B, CS C, CS D, and CS E but not by HS or keratan sulfate. A cross-blocking study indicated that L- and P-selectin recognize close or overlapping sites on versican, whereas CD44 recognizes separate sites. We also show that soluble L- and P-selectin directly bind to immobilized CS B, CS E, and HS and that soluble CD44 directly binds to immobilized hyaluronic acid, CH, and all the CS chains examined. Consistent with these results, structural analysis showed that versican is modified with at least CS B and CS C. Thus, proteoglycans sufficiently modified with the appropriate glycosaminoglycans should be able to bind L-selectin, P-selectin, and/or CD44.
- Published
- 2000
- Full Text
- View/download PDF
28. PAP-1, a novel target protein of phosphorylation by pim-1 kinase.
- Author
-
Maita H, Harada Y, Nagakubo D, Kitaura H, Ikeda M, Tamai K, Takahashi K, Ariga H, and Iguchi-Ariga SM
- Subjects
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, COS Cells, Cloning, Molecular, Humans, Jurkat Cells, Kinetics, Molecular Sequence Data, Pancreatitis-Associated Proteins, Phosphorylation, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins chemistry, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins c-pim-1, Recombinant Proteins chemistry, Recombinant Proteins metabolism, Sequence Alignment, Sequence Homology, Amino Acid, Substrate Specificity, U937 Cells, Annexin A5 metabolism, Proto-Oncogene Proteins metabolism
- Abstract
Protooncogene, pim-1, has been reported to be a predisposition for lymphomagenesis along with myc, and its protein product, Pim-1, has been shown to be a serine/threonine protein kinase, whose activity is involved in proliferation and differentiation of blood cells. The signal transduction pathways neither to nor from Pim-1, however, have been clarified. We have cloned a cDNA encoding a novel Pim-1 binding protein, PAP-1, comprising 213 amino acids with a basic amino-acid cluster near the C-terminus. PAP-1 was colocalized with Pim-1 in human HeLa cell nuclei. The in vitro binding assays using GST fusion proteins of the wild-type and various deletion mutants revealed that the whole molecule of Pim-1 is required for the binding activity to PAP-1 and that Pim-1 binds to the region from amino-acid numbers 1-147 of PAP-1, or to two segments in the region. The association of PAP-1 with Pim-1 was also shown in vivo in transfected cells. Furthermore, PAP-1 was phosphorylated in vitro by Pim-1, but not a kinase-negative Pim-1 mutant. The two serine residues of PAP-1 at amino acids 204 and 206 near the C-terminus were phosphorylated by Pim-1. PAP-1 is thus thought to be a target protein for Pim-1 kinase.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.